| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$635 |
Appendix 4E and Annual Report to Shareholders 2025
|
28 Aug 2025 9:34AM |
$13.550 |
$12.640 |
fallen by
6.72%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Provides the statutory Appendix 4E and Annual Report for Clinuvel Pharmaceuticals Limited for the financial year ended 30 June 2025.
- Summarizes financial performance including revenues, profits, expenses, and earnings per share.
- Highlights business achievements such as product launches, regulatory submissions, and pipeline progress.
- Details the company’s global expansion and commercial strategies.
- Covers key research and development initiatives in pharmaceuticals and photomedicine.
- Discusses corporate governance practices, risk management, and board activities.
- Explains dividend policy, shareholder returns, and financial outlook.
- Affirms the company’s focus on treating rare diseases and advancing photomedicine innovation.
- Includes commentary from senior management and the Board regarding strategic direction and operational priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Inghams Group Limited (ING) ORDINARY FULLY PAID |
Consumer Staple |
$970 |
Change of Director's Interest Notice - M Haseltine
|
28 Aug 2025 9:33AM |
$2.770 |
$2.610 |
fallen by
5.78%
|
|
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$37 |
FY25 results presentation
|
28 Aug 2025 9:33AM |
$0.060 |
$0.068 |
risen by
13.33%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- CCG released its FY25 results presentation, reporting on financial and operational performance.
- The company maintains a focus on organic growth and operational efficiency.
- Key strategic initiatives include technology platform enhancement and streamlined processes.
- The FY25 outlook includes revenue and EBITDA guidance reflecting market opportunities and cost control.
- CCG emphasizes shareholder value creation through disciplined investment and innovation.
- Customer segments, go-to-market strategies, and business drivers are outlined for the year ahead.
- The presentation highlights CCG’s positioning in the communications and technology sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Moho Resources NL (MOH) ORDINARY FULLY PAID |
Materials |
$8 |
Moho stakes new gold project in the Pilbara WA
|
28 Aug 2025 9:33AM |
$0.005 |
$0.008 |
risen by
60%
|
|
MOH - Price-sensitive ASX Announcement
Full Release
Key Points
- Moho Resources NL has entered into an agreement to acquire 85% of the Peak Charles Gold Project in Western Australia.
- The project covers 805 square kilometers in the southern Pilbara Craton.
- Historical data and geophysical surveys indicate strong gold mineralisation potential.
- Moho plans an exploration program including geochemical sampling, geophysical surveys, and reconnaissance drilling.
- The acquisition is part of Moho’s strategy to expand its gold exploration portfolio in Western Australia.
- Key factors for acquisition include the project's strategic location, underexplored nature, and promising geology.
- Details of the agreement, planned exploration activities, and rationale are provided in the announcement.
- Consideration for the acquisition and Moho’s exploration approach are outlined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| De.mem Limited (DEM) ORDINARY FULLY PAID |
Utilities |
$34 |
Appendix 4D and Half Yearly Report and Accounts
|
28 Aug 2025 9:33AM |
$0.105 |
$0.105 |
fallen by
0%
|
|
DEM - Price-sensitive ASX Announcement
Full Release
Key Points
- De.mem Limited achieved a 33% revenue increase for H1 2023 compared to H1 2022.
- Gross profit margin remained steady at 31%.
- EBITDA improved by 37% over the previous corresponding period.
- Net loss after tax was $1.61 million for the half year.
- Strong cash balance at the end of the reporting period.
- Growth was driven across all business units, with Chemicals and Membrane Systems performing strongly.
- Continued focus on higher-margin products and solutions.
- Investment in R&D and expansion of product portfolio.
- No dividends were paid or declared for the reporting period.
- The company is optimistic about continued growth into H2 2023.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Comms Group Ltd (CCG) ORDINARY FULLY PAID |
Communication Services |
$37 |
FY25 financial results announcement
|
28 Aug 2025 9:33AM |
$0.060 |
$0.068 |
risen by
13.33%
|
|
CCG - Price-sensitive ASX Announcement
Full Release
Key Points
- Comms Group Ltd released its FY25 financial results announcement.
- Summary of revenue performance, operational highlights, and year-on-year comparisons.
- Discussion of market trends affecting the communications industry.
- Details on strategic initiatives for sustainable growth and cost management.
- Update on key partnerships and business development activities.
- Management outlook for the next fiscal year and company priorities.
- Emphasis on technological innovation and competitive positioning.
- Commitment to shareholder value, corporate governance, and transparency.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacgold Limited (PGO) ORDINARY FULLY PAID |
Materials |
$47 |
Compelling IP Gold Target Delineated at White Lion Prospect
|
28 Aug 2025 9:32AM |
$0.060 |
$0.110 |
risen by
83.33%
|
|
PGO - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacgold Limited announced new high-resolution IP geophysical survey results at White Lion Prospect.
- Multiple strong IP chargeability and resistivity anomalies have been identified, considered compelling gold targets.
- The anomalies coincide with significant surface geochemistry and geological mapping results.
- White Lion Prospect is now a priority exploration target within the Alice River Gold Project.
- Drill testing of these targets is planned to commence in the coming quarter.
- Results support Pacgold’s growth strategy to expand its gold resources.
- The announcement underscores the prospectivity and exploration upside at White Lion based on integrated geophysical and geological data.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$55 |
Completion of Placement & Institutional Entitlement Offer
|
28 Aug 2025 9:32AM |
$0.185 |
$0.115 |
fallen by
37.84%
|
|
AR9 - Price-sensitive ASX Announcement
Full Release
Key Points
- archTIS Limited completed an institutional placement and entitlement offer raising approximately AUD $6.3 million.
- The combined capital raising aims for a total of up to AUD $10 million.
- The funds will be used for working capital and growth initiatives.
- The placement and entitlement offer were well supported by institutional investors.
- A retail entitlement offer will follow, giving eligible retail shareholders the opportunity to participate.
- The offer price per new share was set at AUD $0.025.
- The capital raising is expected to strengthen archTIS's balance sheet and support its strategic goals.
- Settlement and allotment dates for the new shares are provided in the timetable.
- archTIS received strong support from both new and existing investors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Beam Communications Holdings Limited (BCC) ORDINARY FULLY PAID |
Information Technology |
$7 |
Full Year FY2025 Result Reports & Appendix 4E
|
28 Aug 2025 9:32AM |
$0.130 |
$0.085 |
fallen by
34.62%
|
|
BCC - Price-sensitive ASX Announcement
Full Release
Key Points
- Beam Communications Holdings Limited (BCC) released its Appendix 4E and Full Year Results for the FY2025.
- The company reported a strong financial performance for the period, noting increased revenues compared to the prior year, attributed to higher sales of Iridium satellite communication devices and accessories.
- Operating profit improved, driven by enhanced sales performance, cost management, and product mix optimization.
- BCC highlighted significant progress in international markets, particularly in North America and Asia, contributing to the overall revenue growth.
- During the year, new product development initiatives and the launch of the Iridium GO! exec device supported continued business expansion.
- The company delivered positive cash flow from operations and maintained a solid balance sheet position.
- BCC’s focus remained on innovation and diversification, with investments in R&D and the development of advanced satellite communication solutions.
- Management emphasized its commitment to shareholder value and outlined strategies for sustainable growth, including further market penetration and strengthening distribution partnerships.
- The Board of Directors did not declare a final dividend for the year, as resources are being prioritized for growth initiatives.
- The outlook for FY2026 remains positive, with ongoing demand for satellite communications and the introduction of new products expected to support further growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Betmakers Technology Group Ltd (BET) ORDINARY FULLY PAID |
Consumer Discretionary |
$230 |
Appendix 4G
|
28 Aug 2025 9:32AM |
$0.150 |
$0.205 |
risen by
36.67%
|
|
| FOS Capital Ltd (FOS) ORDINARY FULLY PAID |
Industrials |
$17 |
FOS Capital DRP Plan AUG 2025
|
28 Aug 2025 9:32AM |
$0.300 |
$0.250 |
fallen by
16.67%
|
|
| Patrys Limited (PAB) ORDINARY FULLY PAID |
Health Care |
$9 |
Application for quotation of securities - PAB
|
28 Aug 2025 9:31AM |
$0.002 |
$0.026 |
risen by
1,633.33%
|
|
| Paladin Energy Ltd (PDN) ORDINARY FULLY PAID |
Energy |
$4,767 |
FY2025 Results Presentation
|
28 Aug 2025 9:31AM |
$7.510 |
$10.610 |
risen by
41.28%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,971 |
Final Dividend Declared for FY25 and On-Market Share Buyback
|
28 Aug 2025 9:31AM |
$3.370 |
$6.320 |
risen by
87.54%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Final dividend of 3 cents per share declared for FY25 with a payout ratio of 78%.
- The total dividend payout is $28.3 million, to be paid on 10 October 2025.
- The ex-dividend date is 11 September 2025, and the record date is 12 September 2025.
- Westgold Board has approved an on-market share buy-back program of up to 5% of Westgold shares over the next 12 months.
- The share buy-back reflects confidence in the company's ability to generate future cash flows and return capital to shareholders.
- Record gold production of 326,000 ounces was achieved in FY25.
- Enhanced capital management programme includes an increase in minimum dividend per share from 1 cent to 2 cents for FY26.
- The required minimum net cash balance increased from $100M to $150M after dividend payments for FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,971 |
Final Dividend Declared for FY25 and On-Market Share Buyback
|
28 Aug 2025 9:31AM |
$3.370 |
$6.320 |
risen by
87.54%
|
|
WGX - Price-sensitive ASX Announcement
Full Release
Key Points
- Final dividend of 3cps declared for FY25.
- Dividend payout ratio of 78%.
- Total dividend of $28.3M to be paid out on 10 October 2025.
- On-market Share Buy-Back of up to 5% approved for the next 12 months.
- FY26 dividend policy enhances minimum dividend to 2cps.
- Minimum net cash balance requirement increased to $150M for FY26.
- FY25 marked a transformational year with record gold production.
- Westgold's stock deemed materially undervalued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Austral Gold Limited (AGD) ORDINARY FULLY PAID |
Materials |
$99 |
Austral Gold Announces Filing of 2025 Half Year Report
|
28 Aug 2025 9:31AM |
$0.044 |
$0.160 |
risen by
263.64%
|
|
AGD - Price-sensitive ASX Announcement
Full Release
Key Points
- Announced filing of 2025 Half Year Report for the period ended 31 December 2023
- Provided operational updates on Guanaco-Amancaya and Casposo-Manantiales projects
- Detailed gold and silver production figures and operational performance
- Disclosed financial results including revenues, EBITDA, profit/loss, and cash flow
- Highlighted ongoing exploration efforts and cost management strategies
- Discussed impact of commodity price fluctuations and operational challenges
- Outlined future plans for mine expansion and resource development
- Included governance, risk management, and auditor’s review statements
- Confirmed compliance with financial reporting standards and regulations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$41 |
Strategic partnership with Know Your Lemons Foundation
|
28 Aug 2025 9:31AM |
$0.100 |
$0.125 |
risen by
25%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences Limited announced a strategic partnership with Know Your Lemons Foundation.
- Know Your Lemons Foundation is a global leader in breast cancer education with programs in over 100 countries.
- The partnership aims to increase awareness and education for breast cancer.
- RHY will leverage the Foundation’s campaigns and educational reach to support early detection.
- The collaboration aligns with both organizations’ missions to advance women’s health.
- Benefits include increased exposure for RHY’s diagnostic products and enhanced educational outreach for Know Your Lemons Foundation.
- The partnership is positioned to add value by merging RHY’s diagnostics expertise with the Foundation’s education efforts.
- The announcement underscores both parties’ roles in improving breast cancer outcomes through awareness and innovation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Starpharma Holdings Limited (SPL) ORDINARY FULLY PAID |
Health Care |
$160 |
$3.7M R&D Tax Incentive Received
|
28 Aug 2025 9:30AM |
$0.130 |
$0.380 |
risen by
192.31%
|
|
SPL - Price-sensitive ASX Announcement
Full Release
Key Points
- Starpharma Holdings Limited (ASX: SPL) announced the receipt of a $3.7 million Research and Development (R&D) Tax Incentive Refund.
- The refund is related to eligible R&D activities conducted during the 2023 financial year.
- These activities focused primarily on Starpharma’s proprietary dendrimer product portfolio, including its VIRALEZE™ antiviral nasal spray, DEP® drug delivery platform, and other pharmaceutical development programs.
- The R&D Tax Incentive is a program provided by the Australian Government to encourage companies to engage in R&D that benefits Australia.
- The received funds will support Starpharma’s ongoing research, development, and commercialization initiatives.
- Starpharma’s CEO, Dr. Jackie Fairley, stated that the refund will assist in advancing the company’s product pipeline, particularly in clinical trials and regulatory submissions.
- The announcement reiterates Starpharma’s commitment to innovation and development of novel pharmaceutical products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Energy One Limited (EOL) ORDINARY FULLY PAID |
Information Technology |
$535 |
Change in substantial holding - BW South Asia
|
28 Aug 2025 9:30AM |
$14.200 |
$17.000 |
risen by
19.72%
|
|
| Platinum Capital Limited (PMC) ORDINARY FULLY PAID |
Financials |
$449 |
Update - Notification of buy-back - PMC
|
28 Aug 2025 9:29AM |
$1.510 |
$1.765 |
risen by
16.89%
|
|
| Arika Resources Limited (ARI) ORDINARY FULLY PAID |
Materials |
$35 |
Proposed issue of securities - ARI
|
28 Aug 2025 9:29AM |
$0.041 |
$0.031 |
fallen by
24.39%
|
|
| Dimerix Limited (DXB) ORDINARY FULLY PAID |
Health Care |
$324 |
Appendix 4G and Corporate Governance Statement
|
28 Aug 2025 9:29AM |
$0.475 |
$0.540 |
risen by
13.68%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$61 |
FY2025 Results and Dividend Announcement
|
28 Aug 2025 9:29AM |
$0.087 |
$0.200 |
risen by
129.89%
|
|
VBC - Price-sensitive ASX Announcement
Full Release
Key Points
- Verbrec Limited reported FY2025 revenue of $163.3 million, up 4.2% year-on-year.
- EBITDA increased by 11.3% to $8.6 million.
- Net profit after tax was $3.1 million, a 13.7% improvement from the previous year.
- Strong performance in Energy and Infrastructure divisions.
- Workflow efficiencies and integration of acquisitions contributed to growth.
- The Board declared a fully franked final dividend of 1.5 cents per share.
- Company maintains a robust project pipeline in Australia and New Zealand.
- Strategic focus on infrastructure and digital solutions aimed at sustained growth into FY2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medallion Metals Limited (MM8) ORDINARY FULLY PAID |
Materials |
$310 |
Sulphide Resource Increases to 0.95Moz @ 5.2g/t AuEq
|
28 Aug 2025 9:29AM |
$0.325 |
$0.405 |
risen by
24.62%
|
|
MM8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Sulphide mineral resource at RGP increased to 5.7Mt @ 5.2g/t AuEq for 950,000oz AuEq.
- Represents a 79% increase in contained AuEq and 49% increase in grade over prior estimate.
- Upgrade achieved primarily through targeted exploration and infill drilling at Kundip Mining Centre.
- Main contributions from Harbour View, Flag, and Kaolin deposits.
- Resource remains open along strike and at depth, offering further growth potential.
- Minimal increase in drilling density and cost to achieve upgrade.
- Resource upgrade strengthens the foundation for feasibility studies and development planning.
- High-grade sulphide resource positions Medallion Metals for future value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hartshead Resources NL (HHR) ORDINARY FULLY PAID |
Energy |
$37 |
Suspension from Quotation
|
28 Aug 2025 9:29AM |
$0.006 |
$0.013 |
risen by
116.67%
|
|
HHR - Price-sensitive ASX Announcement
Full Release
Key Points
- Hartshead Resources NL (ASX: HHR) requested a suspension from quotation.
- The suspension is under ASX Listing Rule 17.2.
- The suspension is pending an announcement regarding a transaction related to the P2607 Licence.
- The suspension is to remain until the announcement release or the start of trading on 1 September 2025.
- HHR refers to a trading halt granted on 26 August 2025.
- The request for suspension has been authorized by the Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
